Abstract:In this viewpoint, we argue for the importance of creating data spaces for genomic research that are detached from contexts in which fundamental rights concerns related to surveillance measures override a purpose-specific balancing of fundamental rights. Genomic research relies on molecular and phenotypic data, on comparing findings within large data sets, on searchable metadata, and on translating research results into a clinical setting. These methods require sensitive genetic and health data to be shared across borders. International data sharing between the European Union (EU) or the European Economic Area and third countries has accordingly become a cornerstone of genomics. The EU General Data Protection Regulation contains rules that accord privileged status to data processing for research purposes to ensure that strict data protection requirements do not impede biomedical research. However, the General Data Protection Regulation rules applicable to international transfers of data accord no such preferential treatment to international data transfers made in the research context. The rules that govern the international transfer of data create considerable barriers to international data sharing because of the cost-intensive procedural and substantive compliance burdens that they impose. For certain jurisdictions and select use cases, there exist practically no lawful mechanisms to enable the international transfer of data because of concerns about the protection of fundamental rights. The proposed solutions further fail to address the need to share large data sets of local and regional cohorts across national borders to enable joint analyses. The European Health Data Space is an emerging federated, EU-wide data infrastructure that is intended to function as an infrastructure bringing together EU health data to improve patient care and enable the secondary use of health-related data for research purposes. Such infrastructure is implementing new institutions to support its functioning and is being implemented in reliance on a new enabling law, the regulation on the European Health Data Space. This innovation provides the opportunity to facilitate EU contribution to international genomic research efforts. The draft regulation for this data space provides for a concept of data infrastructure intended to enable cross-border data exchange and access, including access to genetic and health data for scientific analysis purposes. The draft regulation also provides for obligations of national actors aimed at making data widely available. This effort is laudable. However, in the absence of further, more fundamental changes to the manner in which the EU regulates the secondary use of health data, it is reasonable to believe that EU participation in international genomic research efforts will remain impeded.

Genomic Data as a National Strategic Resource: Implications for the Genomic Commons and International Data Sharing for Biomedical Research and Innovation

Enabling responsible public genomics

Public perceptions of international genetic information sharing for biomedical research in China: a case study of the social media debate on the article "A Pangenome Reference of 36 Chinese Populations" published in Nature

Regulatory Barriers to US-China Collaboration for Generative AI Development in Genomic Research

Ethical challenges related to biomedical data sharing in China: A systematic literature review

South Korea: in the midst of a privacy reform centered on data sharing

Teaming Up? China, India and Brazil and the Issue of Benefit-Sharing from Genetic Resource Use

Ethical, Legal, and Social Implications of Genomics in China: A Scoping Review and Implications for Precision Public Health.

Collaborative analysis of genomic data: vision and challenges

The Legal Status and Improvement Path of Human Genetic Data in Gene Therapy in China

The ethics weathervane

Privacy in the Genomic Era

Trends in ethical and legal frameworks for the use of human biobanks

A nation's genes for a cure to cancer: evolving ethical, social and legal issues regarding population genetic databases

Bridging the European Data Sharing Divide in Genomic Science

A call to action to scale up research and clinical genomic data sharing

Toward unrestricted use of public genomic data

Future-proofing genomic data and consent management: a comprehensive review of technology innovations

Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison

Digital sequence information–legal questions for patent, copyright, trade secret protection and sharing of genomic sequencing data

Integrating Genomics into Healthcare: A Global Responsibility